SCHEMBL2451634

SCHEMBL2451634

O=C(O)N1CCC2(CC1)CN(C1CCCC1)C(=O)c1ccccc1O2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.44
CYP2C9 P11712 1/20 0.43
EPHX1 P07099 2/20 0.42
SCN5A Q14524 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
HSD11B1 P28845 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3506901 0.85 SMN1; SMN2 (0.45) EPHX2SIGMAR1HRH3HDAC1HDAC6
SCHEMBL2450084 0.81 ALDH1A1 (0.39) ATM
SCHEMBL4127734 0.81 EPHX2 (0.42) EPHX2CYP2C9EPHX1SCN5ASIGMAR1
SCHEMBL22288737 0.78 OPRM1 (0.36) EPHX2SIGMAR1
SCHEMBL3222598 0.76 SIGMAR1 (0.66) EPHX2CYP2C9EPHX1SCN5ASIGMAR1
SCHEMBL2588053 0.76 SIGMAR1 (0.66) EPHX2CYP2C9EPHX1SCN5ASIGMAR1
SCHEMBL2455451 0.75 CHRM3 (0.48) SIGMAR1
SCHEMBL3213563 0.73 SIGMAR1 (0.60) EPHX2CYP2C9EPHX1SCN5ASIGMAR1
SCHEMBL3213557 0.73 SIGMAR1 (0.60) EPHX2CYP2C9EPHX1SCN5ASIGMAR1
SCHEMBL2449728 0.73 SIGMAR1 (0.48) EPHX2CYP2C9EPHX1SCN5ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364982-A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof ONO Pharmaceutical Co., Ltd. (JP) 2011-09-14 EP disclosed